Our History
From pioneering DNA sequencing technology to becoming a global leader in separation science, our journey has been shaped by innovation, acquisition and a shared passion for advancing science.
Pyrosequencing is founded
Pyrosequencing, the company that would become Biotage, is founded, pioneering technology for DNA sequencing.
Listed on the stock exchange
Pyrosequencing is listed on the stock exchange, marking an important milestone in the company's growth.
Biotage is born
Pyrosequencing acquires Personal Chemistry and Biotage LLC, bringing the three businesses together to create a new Biotage Group. The merger combines expertise across medicinal chemistry, purification and genetic analysis.
Growing our consumables portfolio
American Argonaut Technologies Inc. is acquired, adding an extensive portfolio of solid-phase extraction (SPE) consumables.
Expanding evaporation technology
The V-10 Evaporator is acquired from British company Vapourtec.
A new strategic direction
Biotage sells its Biosystems division and its share in Corbett Life Sciences to German company QIAGEN.
Strengthening our technology portfolio
Biotage acquires Swedish MIP Technologies and its polymer technology, together with the RapidTrace and TurboVap product lines from American company Caliper Life Sciences.
Expanding into China
Biotage establishes a subsidiary in China, strengthening its presence in one of the world's fastest-growing life science markets.
Growing our global presence
Biotage establishes subsidiaries in South Korea and India and invests in biomolecule purification technology in Denmark.
Strengthening environmental and food safety solutions
American Horizon Technology is acquired, expanding Biotage's offering in environmental and food safety applications.
Advancing biomolecular technology
American PhyNexus is acquired, bringing its biomolecular technology into the Biotage portfolio.
Expanding our biomolecule capabilities
ATDbio is acquired, adding expertise in oligonucleotide synthesis.
Astrea Bioseparations joins Biotage
The acquisition of Astrea Bioseparations strengthens Biotage's position as a global leader in chromatography and expands our capabilities in large-molecule purification.
Biotage partners with KKR
Biotage is acquired by global investment firm KKR, marking a new chapter in the company's growth and creating opportunities to further invest in innovation, technology and our people.
Expanding our sample preparation capabilities
Biotage acquires DPX Technologies, strengthening its position in sample preparation and expanding its capabilities in pipette tip technology and applications.